Drug
Lactated Ringer S
Lactated Ringer S: highest development phase Post-Market, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Lactated Ringer's Solution NCT00517127 | Post-Market | Fluid Overload |
Latest
No recent events.
Follow Lactated Ringer S on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.